Thu, March 16, 2023

Koichi Mamegano Upgraded (TAK) to Strong Buy and Held Target at $20 on, Mar 16th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-20-on-mar-16th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Koichi Mamegano of B of A Securities, Upgraded "Takeda Pharmaceutical Company Limited" (TAK) to Strong Buy and Held Target at $20 on, Mar 16th, 2023.

Koichi, nor any peers, have made any analyst calls on TAK in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30